Has Carmen Garcia, MD received payments from drug or device companies?

Yes. Drug and device makers reported $155,537 in general payments to Carmen Garcia, MD across 894 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carmen Garcia, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carmen Garcia, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carmen Garcia, MD

Dermatology · Parumus, NJNPI 1639105331

Payments from drug & device makers

$155,537in general payments, 2019–2025

Across 894 payments — averaging $173.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$111K
Bristol Myers Squibb$12K
Pfizer$9K
Galderma Laboratories, L.p.$4K
Promius Pharma LLC$2K
EPI Health, LLC$2K
plus $15K from 43 others

What the payments were for

Consulting fees$8,8886%
Speaking & faculty fees$109,73371%
Travel & lodging$15,00010%
Food & beverage$21,79414%
Education$1220%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	175	$111,185
Bristol Myers Squibb	30	$12,389
Pfizer	95	$9,219
Galderma Laboratories, L.p.	45	$3,894
Promius Pharma LLC	6	$2,079
EPI Health, LLC	19	$1,890
Almirall LLC	96	$1,535
Novartis	46	$1,531
Arcutis Biotherapeutics, Inc.	28	$1,167
Lilly USA, LLC	29	$1,139
Ortho Dermatologics, A Division Of Bausch Health US, LLC	23	$948
Regeneron Healthcare Solutions, Inc.	23	$857
Journey Medical Corporation	10	$829
Biofrontera Inc.	6	$660
Sun Pharmaceutical Industries Inc.	35	$650
LEO Pharma Inc.	57	$627
E.r. Squibb & Sons, L.L.C.	17	$592
AbbVie	16	$550
Sanofi	19	$486
Incyte Corporation	15	$426
Johnson & Johnson	12	$372
Mayne Pharma Commercial LLC	33	$358
Dermavant Sciences, Inc.	10	$352
UCB, Inc.	5	$288
Verrica Pharmaceuticals Inc.	3	$230
Boehringer Ingelheim	2	$204
Mallinckrodt Hospital Products Inc.	1	$135
Dermira, Inc.	1	$129
VYNE Pharmaceuticals Inc.	1	$125
Botanix SB Inc	5	$105
Gilead	1	$100
Organon	5	$74
Encore Dermatology Inc.	5	$63
Sandoz	3	$51
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$38
Siemens Medical Solutions USA, Inc.	1	$32
GSK	2	$29
Convatec Inc.	1	$25
Sanofi US Services Inc.	1	$24
Kyowa Kirin, Inc.	1	$18
ANI Pharmaceuticals, Inc.	1	$16
Mission Pharmacal Company	1	$16
DUSA Pharmaceuticals, Inc.	1	$15
Taro Pharmaceuticals USA, Inc.	1	$14
Genentech USA, Inc.	1	$14
Glenmark Therapeutics Inc.	1	$14
Sebela Pharmaceuticals Inc.	1	$14
Redhill Biopharma Inc.	1	$13
Aclaris Therapeutics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$155,537 in reported general payments places this provider in the 95th percentile of 394 dermatology providers in New Jersey.

See all dermatology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$136,401

Medicare patients

700

Services billed

1,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	25	$103,622
Dupixent SyringeDupilumab	14	$87,167
Ivermectin	11	$7,072
Metronidazole	47	$2,958
Gentamicin Sulfate	55	$1,712
Ketoconazole	85	$1,467
Doxycycline Hyclate	31	$1,228
Clobetasol Propionate	14	$1,189
Mometasone Furoate	74	$1,104
ValacyclovirValacyclovir Hcl	29	$778
Fluorouracil	12	$698
Ciclopirox	18	$529
Triamcinolone Acetonide	40	$510
NystopNystatin	18	$309
Fluocinonide	19	$278

Paid to pharmacies, not to this prescriber.

Other dermatology in Parumus

Jerry BagelEast Windsor$15.4M
Jonathan DosikGlen Rock$8.4M
Omar NoorSomerset$4.6M
Linda Cappiello-LindsleyHoboken$2.3M
Winston MoyDenville$1.8M
Brian KeeganEast Windsor$1.7M
Jeanine DownieMontclair$1.2M
Adolfo Fernandez ObregonHoboken$1.1M
Mital Patel CohenFlorham Park$799K
Ronald BernardinVoorhees$688K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →